Purchase Order 75N90023P00012
Award Date 11/7/22
Potential Completion Date 8/7/23
Potential Value $170K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
West Chester, PA, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Caredx Lab Solutions Inc. has been awarded a firm fixed price purchase order from the National Institutes of Health Clinical Center valued at two hundred forty-three thousand four hundred eighty dollars ($243,480) to provide next generation sequencing reagent kits. As a subsidiary of Caredx, Inc., Caredx Lab Solutions will supply the specialized molecular testing products to support the agency's genomic analysis research for personalized medicine. No set-aside was utilized for this...
- The National Institutes of Health Clinical Center awarded a $292,972.80 firm fixed-price purchase order to CareDx Lab Solutions Inc. for AlloSeq TX17 Next Generation Sequencing (NGS) reagent kits, with an ultimate completion date of September 30, 2026. The contract, which carries no set-aside designation, represents a continuation of the agency's relationship with CareDx Lab Solutions, a West Chester, Pennsylvania-based manufacturer specializing in genomics-based diagnostic solutions for...
- This federal contract award to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc., was made by the National Institutes of Health (NIH) Clinical Center. The $4,936.40 firm fixed-price purchase order was awarded on March 23, 2018, with a completion date of April 22, 2018. The contract does not have a set-aside designation. Caredx Lab Solutions is a provider of genomics-based solutions for transplant patients, specializing in molecular testing services, diagnostic kits, and related products....
- This is a $120,000.00 firm fixed price purchase order awarded by the Department of Health and Human Services, Centers for Disease Control and Prevention, to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc. The contract is for the provision of next generation sequencing reagents, testing kits, and testing services to support the CDC's Pittsburgh operations in Chamblee, Georgia. Caredx is a for-profit company that provides specialized molecular testing products and services, particularly...
- This is a firm-fixed-price purchase order contract awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc. The $250,000.00 contract is for "Stage 1 Optimization Reagents Cost" in support of research and development of a next-generation sequencing (NGS)-based assay using hybrid capture technology. The purpose is to optimize the probe design, verify and validate the assay, and initiate development of...
- This contract, awarded by the National Institutes of Health (NIH) Clinical Center to CareDx Lab Solutions Inc., provides ALLOSEQ TX17 KITS, FREIGHT, DRY ICE AND GEL PACKS for the NIH's Department of Transfusion Medicine. The $77,500.00 firm fixed-price purchase order has a period of performance from August 1, 2021 to July 31, 2022. CareDx Lab Solutions Inc. is a subsidiary of the parent company CareDx, Inc., a for-profit organization specializing in advanced medical testing products and services...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $140,040.00 firm fixed price purchase order to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc. The contract is for the delivery of 7 ASTX17.1(96)-B-RUO KITS, with a completion date of August 30, 2023. Caredx, Inc. is a for-profit company that provides kidney care solutions, including specialized testing kits and services related to organ transplant patients. The company has previously...
- The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a $156,650.78 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer, for the provision of various sequencing reagents and kits to support the NIH's Center for Cellular Engineering (CCE). This includes NextSeq 500/550 v2.5 sequencing reagent kits, PhiX Control v3 kits, and related technical support. The contract has no set-aside designation and is being issued under...
- The National Institutes of Health (NIH) Clinical Center awarded a firm-fixed-price purchase order to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc., to procure various reagents and supplies needed for clinical patient care testing by the Department of Laboratory Medicine, Hematology Service. The $34,845.94 contract, awarded on November 1, 2024, is for proprietary reagents and consumables specifically designed for use with the existing instruments at the Clinical...
- The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $266,475.00 order was for a NextSeq 550 Sequencing System, shipping, maintenance, software licenses, and technical support to support the NIH Clinical Center's Department of Transfusion Medicine and its blood collection and research activities. The contract was...